Clinical Trial Update: FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma [NA]

View source ↗

Summary

This update notes completion of a trial evaluating FDG-PET-stratified R-DICEP and R-Beam/ASCT approaches for diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-Beam/ASCT
• R-DICEP
• Rituxan (rituximab)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Diffuse Large B Cell Lymphoma | NA | Status: COMPLETED